These findings demonstrate that monoallelic gene loss correlates with a 50% protein reduction for PTEN and ARID1A, confirming that these tumour suppressors can act in a haploinsufficient manner, with positive clone biases in the normal tissue arising from the loss of a single allele (phenotypic haploinsuffiency). Here, ARID1A is linked to neoplasm.